Clinical trial
Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression in PKU "Nonresponders" to Kuvan® (Sapropterin Dihydrochloride)
NCT01274026 is registered in ClinicalTrials.gov with Tulane University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression in PKU "Nonresponders" to Kuvan® (Sapropterin Dihydrochloride)
- Lead sponsor
- Tulane University School of Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- December 31, 2013
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
behavior and behavior mechanisms, pah gene expression, phenylketonuria